Apparatus Included In Process Claim (e.g., Physical Support Structures, Etc.) Patents (Class 436/807)
-
Patent number: 5693539Abstract: Improvements in the existing procedures and materials for conduct of high gradient magnetic separation (HGMS) are disclosed. Superior superparamagnetic particles, optionally coated with a polysaccharide or other, usually organic, materials can be prepared in uniform compositions with homogeneous magnetizations. The coating can conveniently be conjugated to a specific binding moiety complementary to a biological material whose purification or separation is desired. In addition, plastic coated matrices which form superior magnetic gradient-intensifying supports are disclosed, along with improved methods and apparatus to conduct HGMS.Type: GrantFiled: May 31, 1994Date of Patent: December 2, 1997Inventors: Stefan Miltenyi, Andreas Radbruch, Walter Weichel, Werner Muller, Christoph Gottlinger, Klaus Ludwig Meyer
-
Patent number: 5679535Abstract: An apparatus for collecting antigen, including an allergen exemplified by a dust-mite, dispersed in a motile fluid in a given environment that can be inserted in a section of a pipe of a standard vacuum cleaner hose. The apparatus includes a receptacle whose body is formed of nylon, typically with a pore size of from 15 to 60 .mu.m. The receptacle is coated with an antibody that retains the antigen in a contacting relationship. The apparatus is provided with a removable holder, which assists in locating the apparatus in the pipe of the vacuum cleaner. The apparatus can be used directly in an immunoassay for confirming the presence of, or quantifying, the antigen.Type: GrantFiled: December 5, 1994Date of Patent: October 21, 1997Assignee: University Collge DublinInventors: Patrick Joseph Joyce, Edmund Bruce Mitchell, Alan Gaylard Shattock
-
Patent number: 5677196Abstract: Methods and apparatus for evanescent light fluoroimmunoassays are disclosed. The apparatus employs a planar waveguide with an integral semi-cylindrical lens, and has multi-analyte features and calibration features, along with improved evanescent field intensity. A preferred embodiment of the biosensor and assay method have patches of capture molecules each specific for a different analyte disposed adjacent within a single reservoir. The capture molecules are immobilized to the patches on the waveguide surface by site-specific coupling of thiol groups on the capture molecules to photo-affinity crosslinkers which in turn are coupled to the waveguide surface or to a non-specific-binding-resistant coating on the surface. The patches of different antibodies are produced by selectively irradiating a portion of the waveguide surface during the process of coupling the photo-affinity crosslinkers the selective irradiation involving a mask, a laser light source, or the like.Type: GrantFiled: June 22, 1994Date of Patent: October 14, 1997Assignee: University of Utah Research FoundationInventors: James N. Herron, Douglas A. Christensen, Hsu-Kun Wang, Karin D. Caldwell, Vera Janatova, Shao-Chie Huang
-
Patent number: 5677133Abstract: A method is described for performing an affinity assay comprising contacting a sample to be assayed for the presence of an analyte with a dry reagent containing the analyte (hapten, antigen, antibody, receptor, or complementary polynucleotide) bound to a reaction cascade initiator, an antibody or other binding pair partner reactive with said analyte, and magnetic particles, to form an assay mixture in a reaction chamber, incubating the assay mixture, applying an oscillating or moving static magnetic field to the assay mixture, activating the reaction cascade initiator to initiate a reaction cascade, monitoring the response of the magnetic particles to the oscillating or moving static magnetic field to provide a time varying signal, and determining the analyte concentration of the sample by analysis of the time varying signal, as well as a kit for performing the assay and a diagnostic system for performing the assay.Type: GrantFiled: September 11, 1996Date of Patent: October 14, 1997Assignee: Cardiovascular Diagnostics, Inc.Inventor: Bruce J. Oberhardt
-
Patent number: 5670120Abstract: A system for incubating sample liquids is proposed where the incubating vessels are placed into the bores of an incubator block with the aid of a rack. The rack has bores in which the incubating vessels are hanging. The bores of the rack and the ones in the incubator block are adjusted to one another so that the incubating vessels fit into the bores of the incubator block when the rack is placed onto the incubator block.Type: GrantFiled: November 9, 1995Date of Patent: September 23, 1997Assignee: Boehringer Mannheim GmbHInventors: Volker Degenhardt, Manfred Bohm, Alois Rainer, Albert Wohland
-
Patent number: 5668017Abstract: The assay device of this invention provides for very simple assay procedures leading to rapid, sensitive, specific detection of an analyte in a solution. The device is inexpensive and easily manufactured, particularly if automated manufacturing processes are used. The assay device is a test strip having an elongated support sheet of solid non-porous material attached to a similarly shaped sheet of absorbent material. The absorbent sheet has perforations, preferably of circular shape, forming sample receiving wells. Forming the bottom of the sample receiving wells is one surface of the support sheet, and attached to this surface are moieties which specifically bind the analyte (anti-analyte moieties). A liquid sample for assay is placed in the wells, and the liquid is drawn into the absorbent material. As the liquid is absorbed, it flows tangentially across the surface of the support sheet, and across binding moieties specific for the analyte which are attached to the bottom of the wells.Type: GrantFiled: February 10, 1995Date of Patent: September 16, 1997Assignee: PathInventors: Ian Ellis Buchanan, Milton Richard Tam
-
Patent number: 5663050Abstract: A multi-purpose on-line or field-portable system and method for monitoring the presence and concentration of selected antigen-antibody reactions singly or in combination that result from the presence of specific microorganisms or free antigens present or suspended in aqueous solutions, during a given time period. The detection system comprises a detection column and two sensors mounted around the detection column. Each sensor consists of an electromagnetic radiation source and an appropriate detector for the electromagnetic radiation. The reacted analyte tends to accumulate at the sensor located at the bottom detection column. The lower sensor continually nulls against the upper sensor to subtract any optical effects due to non-reactants in the aqueous process or environmental stream. The response from the detector sensors drive an electric circuit, which provides an output signal. In the on-line automatic version, the signal can drive elements of a process system by switching automated valves.Type: GrantFiled: May 11, 1994Date of Patent: September 2, 1997Assignee: Intelligent Monitoring Systems, Inc.Inventor: Glenn W. Bedell
-
Patent number: 5660990Abstract: A method for determining the presence and/or concentration of a target substance e.g. protein, nucleic acid, bioparticle etc. in a fluid sample is provided. The method disclosed combines elements of immunoassays, coated cup assays and magnetic particle separation to effect the quantitation and recovery of an analyte in solution. Also the method ensures the non-reorientation of magnetically collected material by linking the magnetic particles to a collection surface via a specific binding pair. This linkage immobilizes the magnetic-analyte-containing material and thus allows for vigorous washing and reagent addition without significant redistribution or displacement. Thus the assay of this invention offers the speed of diffusion controlled kinetics as in a ferrofluid assay, the speed of collection of labeled target substance as in a magnetic assay as well as the ability to magnetically monolayer the ferrofluid, all of which is combined with the ease of washing and signal detection found in a coated cup assay.Type: GrantFiled: August 18, 1995Date of Patent: August 26, 1997Assignee: Immunivest CorporationInventors: Galla Chandra Rao, Paul A. Liberti
-
Patent number: 5660993Abstract: A disposable diagnostic assay device and method for its use are provided. The device comprises a sample addition port in fluid communication with at least one main channel. The main channel comprises, in the direction of fluid flow, a main reagent area in fluid communication with an incubation area and a waste area. In fluid communication with the main channel is at least one side reagent channel. The side reagent channels comprise, in the direction of fluid flow, a liquid addition port and a side reagent area in fluid communication with the main channel at a region of the main channel upstream from the incubation area. Agitation means may be included in the at least one of the main and side reagent areas and/or the incubation area. Capillary valves may be located at various positions along the main and side reagent channels upstream from the incubation area, providing for control over fluid flow through the device.Type: GrantFiled: August 24, 1994Date of Patent: August 26, 1997Assignee: Biocircuits CorporationInventors: Cheryl A. Cathey, Tom Saul, Nicole D. Bloom, Hans O. Ribi, Henry L. Schwartz, Jeffrey B. Langford
-
Patent number: 5658723Abstract: An analytical system for performing an immunoassay is provided wherein the system contains an element that uses capillary action to draw a sample into a reaction chamber charged with reagent containing an immobilized antibody or immobilized antigen, where reaction between the liquid sample and the reagent is monitored, and optionally contains a method for controlling the moment that transport of the sample from the sample well to the reaction chamber is initiated.Type: GrantFiled: May 23, 1994Date of Patent: August 19, 1997Assignee: Cardiovascular Diagnostics, Inc.Inventor: Bruce Oberhardt
-
Patent number: 5656428Abstract: A system and method for homogeneous bioassay uses acoustic energy emissions. A measurement cell is designed for binding reactions of mobile biorecognition molecules. The binding reaction contained in the measurement cell is for example a ligand/receptor binding reaction or a complementary nucleic acid binding reaction. A passive acoustic energy transducer is coupled to the measurement cell for detecting acoustic energy generated by the binding reaction of mobile biorecognition molecules. The passive acoustic energy transducer generates a corresponding analog electrical signal. A signal conditioner coupled to the passive acoustic energy transducer filters and amplifies the electrical signal. A signal analyzer determines spectra of the conditioned electrical signal corresponding to characteristic acoustic energy emissions of the binding reaction of mobile biorecognition molecules.Type: GrantFiled: September 8, 1994Date of Patent: August 12, 1997Assignee: Biode, Inc.Inventors: Douglas J. McAllister, Ryszard M. Lec
-
Patent number: 5653939Abstract: A method and apparatus are disclosed for identifying molecular structures within a sample substance using a monolithic array of test sites formed on a substrate upon which the sample substance is applied. Each test site includes probes formed therein to bond with a predetermined target molecular structure or structures. A signal is applied to the test sites and certain electrical, mechanical and/or optical properties of the test sites are detected to determine which probes have bonded to an associated target molecular structure.Type: GrantFiled: August 7, 1995Date of Patent: August 5, 1997Assignees: Massachusetts Institute of Technology, Houston Advanced Research Center, Baylor College of MedicineInventors: Mark A. Hollis, Daniel J. Ehrlich, R. Allen Murphy, Bernard B. Kosicki, Dennis D. Rathman, Chang-Lee Chen, Richard H. Mathews, Barry E. Burke, Mitch D. Eggers, Michael E. Hogan, Rajender Singh Varma
-
Patent number: 5646049Abstract: Apparatus and method for simultaneously performing at least two assays using certain reagents for a plurality of liquid samples on a continuous analytical system is disclosed. The method comprising the steps of combining an aliquot of each liquid sample with at least one reagent in a first reaction container to form a first assay reaction for each liquid sample, and combining an aliquot of each liquid sample with at least one of the other reagents in a second reaction container to form a second assay reaction for each liquid sample. The method further comprises the steps of incubating the assay reactions of each assay being conducted at least one time, and performing other activities associated with each assay and using the first and second assay reactions to complete each assay, including analyzing the incubated assay reactions.Type: GrantFiled: January 3, 1994Date of Patent: July 8, 1997Assignee: Abbott LaboratoriesInventor: Apparao Tayi
-
Patent number: 5645996Abstract: Sets and libraries of sets of polypeptides that are related in sequence to melittin are disclosed that have antimicrobial, hemolytic and hydrolyrically catalytic activities, as are processes for making and using the same. A contemplated set is a mixture of equimolar amounts of a polypeptide of SEQ ID NO:2, and more preferably SEQ ID NO:3.Type: GrantFiled: August 24, 1994Date of Patent: July 8, 1997Assignee: Torrey Pines Institute for Molecular StudiesInventors: Sylvie Blondelle, Richard A. Houghten, Enrique Perez-Paya
-
Patent number: 5637458Abstract: A system for biomolecular separation and detection of a molecular species includes a solid state laser detector having a sample channel therein. The presence of a molecular species is indicated by a frequency shift in the laser's output, which is detected by optical heterodyning the laser's output with the output of a reference laser. The interior of the sample channel is optionally coated with a ligand for binding the molecular species of interest. The system involves preprocessing a sample by electroosmotic separation in channels that are lithographically formed in a two-dimensional planar substrate. Molecular separation is also accomplished in a nanostructural molecular sieve comprising spaced apart posts defining narrow channels therebetween.Type: GrantFiled: July 20, 1994Date of Patent: June 10, 1997Assignee: Sios, Inc.Inventors: Robert Frankel, James M. Forsyth
-
Patent number: 5637469Abstract: Disclosed are devices for detecting the presence of a preselected analyte in a fluid sample. The devices comprise a substrate microfabricated to define a sample inlet port, and a mesoscale flow system that includes a sample flow channel extending from the inlet port. The mesoscale flow system further includes an analyte detection region in fluid communication with the flow channel comprised of a binding moiety for specifically binding the analyte. The detection region is constructed with a mesoscale dimension sufficiently small to enhance binding of the binding moiety and the analyte. The binding moiety may be immobilized in the detection region. The mesoscale detection systems of the invention may be used in a wide range of applications, including the detection of cells or macromolecules, or for monitoring reactions or cell culture growth.Type: GrantFiled: November 30, 1994Date of Patent: June 10, 1997Assignee: Trustees of the University of PennsylvaniaInventors: Peter Wilding, Larry J. Kricka, Jay N. Zemel
-
Patent number: 5635358Abstract: Disclosed are devices and methods for analyzing a fluid cell containing sample. The devices are composed of a solid substrate, microfabricated to define at least one sample inlet port and a mesoscale flow system. The mesoscale flow system includes a sample flow channel, extending from the inlet port, and a cell handling region for treating cells disposed in fluid communication with the flow channel. The devices may further include a component for inducing flow of cells in the sample through the flow system. In one embodiment, the cell-handling region may include a cell lysis component to enable the lysis of cells in the sample, prior to, e.g., the detection of an intracellular component in the cell sample. In another embodiment, the cell handling region may have a cell capture region, with binding sites which reversibly bind to a specific population of cells in the cell sample, to permit the isolation of the specific cell population from the sample.Type: GrantFiled: February 14, 1994Date of Patent: June 3, 1997Assignee: Trustees of the University of PennsylvaniaInventors: Peter Wilding, Larry J. Kricka, Jay N. Zemel
-
Patent number: 5629164Abstract: The present invention relates to an enzyme reagent ticket for conducting diagnostic or serological tests. More particularly, the present invention relates to an enzyme reagent device which allows for a low-cost, disposable, rapid and convenient system for use in the determination of various components in test fluids, and to a diagnostic kit including the device according to the present invention for conducting certain immunochemical, diagnostic or serological testing.Type: GrantFiled: November 25, 1992Date of Patent: May 13, 1997Assignee: Southern Research InstituteInventor: Douglas B. Rivers
-
Patent number: 5622831Abstract: Methods and devices are disclosed which are useful for collecting magnetic materials in either internally or externally generated magnetic gradient fields, followed by resuspension into solution with a simple manipulation of the magnetic device. The methods provide for removal of excess reagent, washing of magnetic material, and resuspension for analysis, among other uses. The methods are applicable to all types of biological material that are susceptible to magnetic labelling, including, for example, cells, viruses, proteins, hormones, and receptor-ligand complexes. Several devices are disclosed to take advantage of the method for cellular and immunoassay applications, including both internal and external devices. Both flow-through and static separators are disclosed.Type: GrantFiled: June 7, 1995Date of Patent: April 22, 1997Assignee: Immunivest CorporationInventors: Paul A. Liberti, Yozhou Wang
-
Patent number: 5610077Abstract: A process for carrying out a specific binding assay by reacting (a) a sample under assay for the possible presence of a substance being tested for, (b) a specific binding partner for the substance being tested for, immobilised on a solid support, and (c) a specific binding partner for the substance being tested for which is conjugated to a detectable marker, to thereby form a complex by reacting between whatever quantities are present of the substance being tested for in (a) with reagents (b) and (c). The marker is immobilised to the support via the substance being tested for, and is detected or assayed as an index of the quantity present in the sample (a) of any of the substance. The reaction ingredients (a), (b) and (c) are all mixed in a single step for reaction in a single reaction liquid.Type: GrantFiled: July 19, 1994Date of Patent: March 11, 1997Assignee: Unilever Patent Holdings B.V.Inventors: Paul J. Davis, Philip Porter
-
Patent number: 5604105Abstract: A diagnostic test, and a device for conducting the test, for assessing whether patient chest pain is cardiac in origin and for differentiating between unstable angina and myocardial infarction as a cause of patient chest pain is described. The diagnostic test comprises simultaneously detecting at least three selected cardiac markers with the use of at least three different monoclonal or polyclonal antibody pairs, each member of which is complementary to a different marker, which is released by heart muscle at varying stages after the onset of chest pain and is indicative of the cause of the chest pain.Type: GrantFiled: April 11, 1995Date of Patent: February 18, 1997Assignee: Spectral Diagnostics Inc.Inventor: George Jackowski
-
Patent number: 5601980Abstract: A method and apparatus is provided for spotting a biological probe onto an array. A micropipette containing a quantity of the biological probe in solution is manipulated to a position above a selected location within the array. The micropipette is pressurized sufficiently to produce a droplet of the biological probe at an open tip of the micropipette. Formation of the droplet is simultaneously visually monitored during the pressurization of the micropipette in order to estimate a volume measurement of the droplet. Upon reaching a predetermined volume for the droplet, the pressurizing of the micropipette is discontinued. The droplet of the predetermined volume is then dispensed onto the selected location.Type: GrantFiled: September 23, 1994Date of Patent: February 11, 1997Assignee: Hewlett-Packard CompanyInventors: Gary B. Gordon, Scott A. Conradson, Kay Lichtenwalter
-
Patent number: 5602042Abstract: An apparatus and method provide automated collection and transfer of particles from a liquid suspension to a glass slide for visual examination. A magnet is positioned adjacent to a solution which contains particles tagged with magnetic beads, for example cells, so that the magnetic particles flow toward the magnet and collect against a collection surface positioned between the particles and the magnet. A transfer mechanism applies a selected pressure to a second side of the collection surface for transferring collected cells to a viewing slide. The apparatus includes a device for dispersing the liquid suspension of particles prior to the collection process and for collecting particles against the collection surface with a spatial distribution advantageous for visual examination. The transfer operation maintains this spatial distribution.Type: GrantFiled: April 14, 1994Date of Patent: February 11, 1997Assignee: Cytyc CorporationInventor: Fredric Farber
-
Patent number: 5601991Abstract: A method is described for performing an affinity assay comprising contacting a sample to be assayed for the presence of an analyte with a dry reagent containing the analyte (hapten, antigen, antibody, receptor, or complementary polynucleotide) bound to a reaction cascade initiator, an antibody or other binding pair partner reactive with said analyte, and magnetic particles, to form an assay mixture in a reaction chamber, incubating the assay mixture, applying an oscillating or moving static magnetic field to the assay mixture, activating the reaction cascade initiator to initiate a reaction cascade, monitoring the response of the magnetic particles to the oscillating or moving static magnetic field to provide a time varying signal, and determining the analyte concentration of the sample by analysis of the time varying signal, as well as a kit for performing the assay and a diagnostic system for performing the assay.Type: GrantFiled: February 13, 1995Date of Patent: February 11, 1997Assignee: Cardiovascular Diagnostics, Inc.Inventor: Bruce J. Oberhardt
-
Patent number: 5578495Abstract: Apparatus, and process, for extracting organic fluids and solids specimens from weighed amounts of semi-solids and solids samples for collection, concentration and transfer to an analytic unit. The organic specimen is picked up by a probe assembly from a single compartment septum-sealed vial by heating and slurrying the sample, contacting with a gas; and then transferring the organic specimen with the gas to a collection device, e.g., a syringe or adsorbent trap. The specimen is then transported to an analytical instrument for analysis.Type: GrantFiled: April 3, 1995Date of Patent: November 26, 1996Assignee: Dynatech Precision Sampling CorporationInventor: Terry S. Wilks
-
Patent number: 5578455Abstract: There is disclosed a method for determining an endotoxin by reacting the endotoxin adsorbed on an adsorbent having specific endotoxin adsorbability with an endotoxin detecting reagent, including the steps of:(a) preparing a column having a tip opening, a rear end opening and an adsorbent-filling and holding means provided in the column through which a sample solution can pass,(b) introducing the endotoxin adsorbent into the column through the tip opening to fill and hold the adsorbent therein,(c) introducing the sample solution into the column through the tip opening and discharging the introduced sample solution through the rear end opening to contact the sample and the adsorbent and thereby adsorbing the endotoxin on the adsorbent, and(d) reacting the detecting reagent with the endotoxin adsorbed on the adsorbent.There is also disclosed an apparatus for the above method.Type: GrantFiled: March 14, 1994Date of Patent: November 26, 1996Assignee: Tanabe Seiyaku Co., Ltd.Inventors: Tetsuya Tosa, Takeji Shibatani, Taizo Watanabe, Satoshi Minobe, Makoto Masuda
-
Patent number: 5576220Abstract: The invention relates to methods and systems of unhindered construction and display of tethered organic ligand molecules, and more particularly to preparation and use of thin film, substantially non-crosslinked hydrophilic polar multi-functionalized polymers (HPMPs) anchored to a variety of functionalized substrates so that the HPMP forms a thin film matrix layer providing a unique highly hydrated, high dielectric environment equivalent to an aqueous solution, for affinity binding of Ligands (L) to Tagged Target Molecules (TTMs). Ligands, and especially MER.sub.n ligand libraries such as peptide libraries, are singly tethered to the HPMP by a "permanent" strong covalent bond so that subsequent displacement of the TTM does not also displace the ligand from the HPMP, thereby making the HPMP tethered Ligand library reusable. The HPMP thin film is on the order of 200-2000 .ANG.Type: GrantFiled: February 19, 1993Date of Patent: November 19, 1996Assignee: Arris Pharmaceutical CorporationInventors: Derek Hudson, Charles R. Johnson, Michael J. Ross, Kevin R. Shoemaker, Robert T. Cass, Lutz B. Giebel
-
Patent number: 5576215Abstract: An improved biological sample analyzer, and a method and system for operation thereof, wherein instrument systems used to perform assays of the biological samples loaded into the analyzer are operated in accordance with a schedule developed by a scheduler routine. The scheduler routine determines interval periods between operations performed by the analyzer instrument systems on each biological sample as a function of an entered load list unless a fixed interval period between the operations is required and schedules instrument system operations and the determined interval periods. The biological system analyzer performs assays of the biological samples by operating the analyzer instrument systems in accordance with the developed schedule.Type: GrantFiled: June 3, 1991Date of Patent: November 19, 1996Assignee: Abbott LaboratoriesInventors: Kathleen L. Burns, Ilya Ratner, Jeanine T. Douglas, Erica J. Kline, Cass J. Grandone
-
Patent number: 5573919Abstract: An assay for detecting an analyte which comprises applying a sample containing analyte to a surface of an absorbent material having at least one binder for the analyte supported on at least a portion of the surface. The absorbent material has a porosity which is capable of retaining non-charged particles having a size of at least 0.1 micron and no greater than 10 microns on the surface thereof. The sample flows past the binder and into the absorbent material. Porous plastics or ceramics are preferred absorbent materials.Type: GrantFiled: May 24, 1993Date of Patent: November 12, 1996Assignee: Carter-WallaceInventors: Kevin Kearns, Richard McPartland
-
Patent number: 5569589Abstract: An immunoassay element for quantitatively analyzing a ligand by determining the change in enzymatic activity caused by a reaction between the ligand, a linked product of the ligand and a high molecular weight compound and an enzyme-labelled antibody. The immunoassay element comprises a substrate layer containing a non-diffusible substrate which forms a diffusible material in the presence of the enzyme, and a reagent layer containing a fragmenting enzyme for further fragmenting the non-difussible material. Also provided is a process for quantitatively analyzing a ligand contained in a sample by the use of the immunoassay element.Type: GrantFiled: December 7, 1993Date of Patent: October 29, 1996Assignees: Fuji Photo Film Co., Ltd., Fujirebio Inc.Inventors: Toshikage Hiraoka, Tetsuji Tanimoto, Yoshihiko Makino, Tadashi Ninomiya, Naofumi Hora, Yoshihiro Ashihara, Yukio Sudo, Toshihiro Mori
-
Patent number: 5565319Abstract: Compositions derived from a novel viral isolate designated feline T-lymphotropic lentivirus (FTLV) include the whole virus; proteins, polypeptides and, polynucleotide sequences derived from the virus; and antibodies to antigenic sites on the virus. These compositions are useful in a variety of techniques for the detection of and vaccination against FTLV. Detection methods disclosed include immunoassays for both the virus and antibodies to the virus, and the use of polynucleotide probes to detect the viral genome. Vaccines include both wholly and partially inactivated viruses and subunit vaccines. Whole, live virus is also useful as a model system for predicting the behavior of human immunodeficiency virus (HIV).Type: GrantFiled: April 12, 1994Date of Patent: October 15, 1996Assignee: The Regents of the University of CaliforniaInventors: Niels C. Pedersen, Janet K. Yamamoto
-
Patent number: 5556789Abstract: Device for the determination of analytes having a sample application point, several separate sample withdrawal zones that are each connected with the sample application point by one capillary transport path and that have several test elements for the individual determination of analytes wherein a retardation zone is provided on at least one of the transport paths. Material for the capillary transport of a liquid sample defines a sample application zone and a plurality of sample withdrawal zones connected to said application zone by a like plurality of transport paths. At least one of said paths has a retardation zone which assures that liquid applied to said application zone arrives simultaneously at said withdrawal zones, regardless of the lengths of the paths.Type: GrantFiled: July 1, 1994Date of Patent: September 17, 1996Assignee: Boehringer Mannheim GmbHInventors: Ada Goerlach-Graw, Reinhard Baer, Rolf Lerch
-
Patent number: 5552272Abstract: Device for detecting the presence or amount of an analyte of interest, comprising a reflective solid, optical support and a label capable of generating fluorescent signal upon excitation with a suitable light source wherein said support comprises an attachment layer comprising a chemical selected from the group consisting of dendrimers, star polymers, molecular self-assembling polymers, polymeric siloxanes, and film forming latexes wherein the support provides an enhanced level of exciting photons to the immobilized fluorescent label compound, and wherein the support also increases the capture of fluorescent signal.Type: GrantFiled: June 10, 1993Date of Patent: September 3, 1996Assignee: Biostar, Inc.Inventor: Gregory R. Bogart
-
Patent number: 5550061Abstract: A swab is impregnated with a test reagent such that a test for a specific substance can be effected by rubbing the impregnated swab over the surface to be tested and then viewing the swab for a reagent reaction. The swab may have a hollow stem, and within the hollow stem is a cartridge within another cartridge. An activator solution is in one of the cartridges and a reagent is in another of the cartridges. A method for testing for a substance includes impregnating a swab, and rubbing the swab over a surface suspected of containing the substance. If the substance is present in the surface, a reaction with the substance produces an easily detectable color on the swab tip.Type: GrantFiled: October 20, 1994Date of Patent: August 27, 1996Assignee: HybriVet Systems, Inc.Inventor: Marcia J. Stone
-
Patent number: 5541072Abstract: Methods and devices are provided for separation of magnetic particles and/or magnetic-associated substances from non-magnetic associated substances and media. The methods are specifically applicable to biological separation, and utilize a phase phenomenon arising from mutual interactions between suspended magnetic particles and interactions with the suspension medium. The phenomenon is exploited to produce and maintain a distinct, structured phase of magnetic particles, or ferrophase, within a multi-phase liquid system. A ferrophase is established within a separation chamber prior to introducing therein a test sample containing the target substances to be separated. The formation of a ferrophase is used to transport target substances from regions of relatively low magnetic field gradient to regions of relatively high magnetic field gradient within a high-gradient magnetic separation apparatus.Type: GrantFiled: April 18, 1994Date of Patent: July 30, 1996Assignee: Immunivest CorporationInventors: Yuzhou Wang, Weixin Tang, William J. Cronin, Paul A. Liberti
-
Patent number: 5536475Abstract: An apparatus for magnetic cell separation using paramagnetic microbeads includes a base upon which is movably carried a rocker member. The rocker member carries both a primary processing container in which a mixture of liquid with cells and paramagnetic microbeads is received; and a primary magnet movable from a first position adjacent to the primary container to magnetically capture the microbeads, and a second position spaced from the primary container to magnetically release the microbeads. The mixture of liquid with cells and microbeads is agitated by tilting motions of the rocker assembly, thereby achieving the binding of target cells to microbeads. The paramagnetic microbeads, with bound target cells, are captured and released by movements of the primary magnet between its first and second positions. A secondary magnet is placed downstream from the primary magnet to capture any paramagnetic microbeads which might escape from the primary magnet.Type: GrantFiled: March 14, 1994Date of Patent: July 16, 1996Assignee: Baxter International Inc.Inventors: Ahmad-Maher Moubayed, R. Alan Hardwick
-
Patent number: 5532122Abstract: For isotopes decaying by capture of an inner shell electron by the nucleus, coincident emission of X-ray and gamma photons may occur. The X-ray results from the drop of an outer shell electron to fill the S shell. The gamma results from the transition of the excited daughter nucleus to a lower energy state. The invention disclosed is a Coincident Gamma and X-ray Detector (CGXD) which achieves extraordinary background rejection by a synergistic combination of coincident counting and other background suppression measures. Whereas the background registered by single gamma counters is of the order of 20-40 counts per minute, a CGXD optimized for the electron capture radioisotope I.sup.125 has a background of about one count per day.Type: GrantFiled: October 12, 1993Date of Patent: July 2, 1996Assignee: BioTraces, Inc.Inventor: Andrzey K. Drukier
-
Patent number: 5529899Abstract: The present invention is directed to a method of detecting dioxin-like compounds in a test sample. The test sample is contacted with a heteromer formed from a plurality of proteins, one of which is an inactive Ah receptor. If dioxin-like compounds are present in the test sample, they will bind to the Ah receptor causing it to dissociate from the heteromer as a complex containing active Ah receptor bound to a dioxin-like compound ligand. The presence of the complex is then detected. The process of the present invention can be practiced utilizing solid phase capture, competitive, and sandwich immunoassay test kit formats.Type: GrantFiled: July 27, 1993Date of Patent: June 25, 1996Assignee: Cornell Research Foundation, Inc.Inventors: Geoffrey D. Wheelock, John G. Babish
-
Patent number: 5527672Abstract: A portion of a hydrophobic membrane, having an unknown concentration of a first molecule in a sample bound to its surface, is incubated with a second molecule that selectively binds to the first molecule so as to allow determination of its concentration. The membrane is first coated with the first molecule and then dried to render the uncoated portion nonwettable with water. The labeled second molecule selectively binds to the first molecule in the absence of a blocking agent on the membrane.Type: GrantFiled: October 24, 1994Date of Patent: June 18, 1996Assignee: Millipore Investment Holdings LimitedInventors: Michael A. Mansfield, Larry Sivik
-
Patent number: 5527673Abstract: Apparatus for transport of molecules including nucleic acid sequences in a bibulous carrier comprising a dry bibulous carrier defining a capillary transport path which supports the transport of the molecules when contacted with a solution containing the molecules.Type: GrantFiled: September 14, 1994Date of Patent: June 18, 1996Assignee: Orgenics Ltd.Inventors: Avraham Reinhartz, Sarah Alajem, Thierry Paper, Max Herzberg
-
Patent number: 5527711Abstract: A method is provided for detecting an analyte of interest in a sample. The method involves binding the analyte to the surface of a substrate through a biotin-biotin binding protein interaction, contacting the surface-bound analyte with a quantitatively detectable analyte-binding moiety that binds thereto, measuring the quantity of detectable moiety bound to the substrate surface and deriving therefrom the quantity of analyte in solution. A preferred use for the present method is in conjunction with a piezoelectric surface transverse wave device. Novel reagents useful for carrying out the inventive method are provided as well.Type: GrantFiled: December 13, 1993Date of Patent: June 18, 1996Assignee: Hewlett Packard CompanyInventors: May Tom-Moy, Joel Myerson, Karla M. Robotti
-
Patent number: 5518887Abstract: The present invention relates to immunoassay methods for detecting and measuring the amount of an analyte in a sample by means of generic anti-hapten antibodies. Also disclosed are multi-analyte immunoassay methods. Reagents, devices, and kits using the anti-hapten antibodies are also disclosed. The present invention also relates to immunoassay methods for detecting and measuring the amount of an analyte in a sample by means of a dual antibody format.The present invention also relates to dyed erythrocytes, preferably fixed, which are coated with antibodies. Also disclosed is the use of these dyed erythrocytes in agglutination assays to detect and measure the presence of an analyte in a sample. The analyte can be a hapten, an antigen, or an antibody. Also included are agglutination assays, compositions and kits using these dyed and coated erythrocytes.Type: GrantFiled: December 1, 1993Date of Patent: May 21, 1996Assignee: Abbott LaboratoriesInventors: Robert G. Parsons, Robert Kowal
-
Patent number: 5514601Abstract: A method of and apparatus for the presence of a target species in a sample taken from or consisting of a mixture of species, comprising the steps of introducing one or more electrical diodes into the mixture prior to taking the sample from the mixture, in such a manner that the presence of diodes in the sample is dependent on the presence of the target species in the sample; passing an alternating electrical signal having a known waveform through the sample; and detecting the modification of the waveform of the signal emerging from the sample due to the presence of the diode or diodes in the sample.Type: GrantFiled: January 17, 1995Date of Patent: May 7, 1996Assignee: Boehringer Mannheim GmbHInventor: Paul J. Reilly
-
Patent number: 5514330Abstract: Automatic apparatus for immunological assay, in which reaction vessels containing samples to be analyzed and reagents are carried by a rotary module which is rotated stepwise, and which is associated with a washing head including needles for sucking up and for injecting liquid for washing magnetic particles in the reaction vessels, and additional needles for sucking up and for injecting a cleaning or washing liquid for the reaction vessels.Type: GrantFiled: December 22, 1994Date of Patent: May 7, 1996Assignee: Laboratoires Merck-ClevenotInventors: Michel Uzan, Thierry Gicquel
-
Patent number: 5503985Abstract: A disposable diagnostic device and method of its use are provided. The device comprises a housing containing first and second flow paths orthogonal to each other. The first flow path commences at a sample addition port and continues through a transport channel which feeds sample to an incubation area by means of capillary flow. The incubation area comprises a signal producing system and is underneath an optically-clear window. The first flow path terminates in a top waste reservoir which receives sample and wash fluid. The second flow path begins on one side of the incubation area at an inlet port over a side reagent reservoir. Liquid flows along the second flow path from the side reagent reservoir across the incubation area into the side waste reservoir. The incubation area may comprise agitation means for homogenous dispersion of reagent into liquid.Type: GrantFiled: January 7, 1994Date of Patent: April 2, 1996Inventors: Cheryl A. Cathey, Henry L. Schwartz, Tom Saul, Jeffrey D. Langford
-
Patent number: 5501984Abstract: The unit has three rotors, namely a reagent rotor (1), a sample rotor (2) and a reaction rotor (3). Each rotor has seats for vessels, which are arranged in circles about the respective rotor axis. At least two of the rotors (1, 2) are arranged concentrically to one another. The rotors can be brought into a plurality of rotating positions in which at least one of the openings (5b, 7b, 8b) is located in a predetermined liquid handling position (LH position).A liquid handling unit (LH unit) comprises a liquid transfer needle (18) which is movable by a transfer needle moving apparatus in such a way that the movement path (23) crosses at least one LH position of each circle of openings (5b, 7b, 8b) on each rotor (1, 2, 3).It thus become possible with a simply designed layout to carry out a wide range of heterogeneous immunological analyses in a flexible manner.Type: GrantFiled: June 17, 1993Date of Patent: March 26, 1996Assignee: Boehringer Mannheim GmbHInventors: Meinrad Hofstetter, Klaus Leckebusch, Armin Panzer
-
Patent number: 5501986Abstract: A piezoelectric crystal-based specific binding assay in which a sol is used to increase the mass of binding reagents to amplify responses to analyte.Type: GrantFiled: July 28, 1994Date of Patent: March 26, 1996Assignee: E. I. Du Pont de Nemours and CompanyInventors: Michael D. Ward, Richard C. Ebersole
-
Patent number: 5500187Abstract: An assay device for detecting the presence of analytes in an unknown sample including a reaction system wherein storage reservoirs containing reagent are fluidly connected to a track containing the sample. An actuation mechanism forces the reagent from the reservoirs and into the track where it mixes the reagents together and then with the sample at a first flow rate. The mechanism then reduces the force on the reagent to allow a second flow rate less then the first flow rate to force the reagent and sample mixture through the track so that reaction can occur, whereby a determination as to whether the target analyte was present may be made.Type: GrantFiled: December 8, 1992Date of Patent: March 19, 1996Assignee: Westinghouse Electric CorporationInventors: James H. Deoms, Daryl S. Mileaf, Kevin E. LaCour, Noe E. Rodriguez, II, Joseph M. Leginus, Scott D. Johnson, Richard C. Kapraun, Richard M. Young
-
Patent number: 5498392Abstract: Disclosed are devices for amplifying a preselected polynucleotide in a sample by conducting a polynucleotide polymerization reaction. The devices comprise a substrate microfabricated to define a sample inlet port and a mesoscale flow system, which extends from the inlet port. The mesoscale flow system includes a polynucleotide polymerization reaction chamber in fluid communication with the inlet port which is provided with reagents required for polymerization and amplification of a preselected polynucleotide. In one embodiment the devices may be utilized to implement a polymerase chain reaction (PCR) in the reaction chamber (PCR chamber).Type: GrantFiled: September 19, 1994Date of Patent: March 12, 1996Assignee: Trustees of the University of PennsylvaniaInventors: Peter Wilding, Larry J. Kricka
-
Patent number: 5494830Abstract: Apparatus for performing determinations of immune reactants (e.g., antigens, antibodies) in bodily fluids includes multiple test units having respective elongated rods with transversely-expanded tips at their distal ends. The tips are each coated with respective immune reactants (e.g., allergens) which react in a known manner with respective allergen-specific or allergen-binding antibodies in human serum. The test units are color-coded to identify the allergen coatings and are supported at their proximal ends and positionally identified on a strip. By correlating the color code to a chart, the specific immune reactant (e.g., allergen) coating can be easily identified. The supporting strip for the test unit has through-holes which frictionally engage the proximal ends of the test unit rods with a spacing that permits all of the supported test units to be simultaneously inserted into an assembly of reaction containers arranged in a linear array.Type: GrantFiled: August 25, 1994Date of Patent: February 27, 1996Inventor: Thomas T. Hubscher